Peroxisome proliferator-activated receptor α is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3241-3248

  Collett, Gavin P ^a   Betts, Alan M ^a   Johnson, Mark I ^a   Pulimood, Anna B ^a   Cook, Susan ^a   Neal, David E ^a   Robson, Craig N ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; GENE EXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANDROGENS; BLOTTING, NORTHERN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NANDROLONE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TESTOSTERONE CONGENERS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033889189     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Reddy, J. K., and Lalwani, N. D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticisers to humans. CRC Crit. Rev. Toxicol., 12: 1-58, 1983.
2. Reddy, J. K., and Rao, M. S. Peroxisome proliferators and cancer: mechanisms and implications. Trends Pharmacol. Sci., 7; 438-443, 1986.
3. Moody, D. E., Reddy, J. K., Lake, B. G., Popp, J. A., and Reese, D. H. Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol., 16: 233-248, 1991.
4. Green, S. Peroxisome proliferators: a model for receptor mediated carcinogenesis. Cancer Surv., 14: 221-232, 1992.
5. Sharma, R., Lake, B. G., and Gibson, G. G. Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-2-ethylhexyl)phthalate. Biochem. Pharmacol., 37: 1203-1206, 1988.
6. Rao, M. S., and Reddy, J. K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis (Lond.), 8: 631-636, 1987.
7. Bardot, O., Aldridge, T. C., Latruffe, N., and Green, S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun., 192: 37-45, 1993.
8. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., and Evans, R. M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (Lond.), 358: 771-774, 1992.
9. Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., and Evans, R. M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA, 91: 7355-7359, 1994.
10. Motojima, K., Peters, J. M., and Gonzalez, F. J. PPARα mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse. Biochem. Biophys. Res. Commun., 230: 155-158, 1997.
11. Lee, S. S-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol., 15: 3012-3022, 1995.
12. Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., and Gonzalez, F. J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor a (PPARα). J. Biol. Chem., 273; 5678-5684, 1998.
13. Peters, J. M., Hennuyer, N., Staels, B., Fruchart, J-C., Fievet, C., Gonzalez, F. J., and Auwerx, J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J. Biol. Chem., 272: 27307-27312, 1997.
14. Auboeuf, D., Vallier, P., Vega, N., Riou, J. P., Laville, M., and Vidal, H. Tissue distribution of PPAR mRNAs in human: obesity and NIDDM are not associated with altered expression in adipose tissue. Diabetes, 46: 650, 1997.
15. Guan, Y. F., Zhang, Y. H., Davis, L., and Breger, M. D. Expression of peroxisome proliferator activated receptors in urinary tract of rabbits and humans. Am. J. Physiol., 42: F1013-F1022, 1997.
16. Palmer, C. N. A., Hsu, M-H., Griffin, K. J., Raucy, J. L., and Johnson, E. F. Peroxisome proliferator activated receptor-α expression in human liver. Mol. Pharmacol., 53: 14-22, 1998.
17. Hertz, R., Bishara-Shieban, J., and Bar-Tana, J. Mode of action of peroxisome proliferators as hypolipidemic drugs, suppression of apolipoprotein C-III. J. Biol. Chem., 270: 13470-13475, 1995.
18. Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., and Wahli, W. Regulation of the peroxisome proliferator-activated receptor a gene by glucocorticoids. J. Biol. Chem., 269: 24527-24530, 1994.
19. Shalev, A., Siegristkaiser, C. A., Yen, P. M., Wahli, W., Burger, A. G., Chin, W. W., and Meier, C. A. The peroxisome proliferator-activated receptor-α is a phosphoprotein: regulation by insulin. Endocrinology, 137: 4499-4502, 1996.
20. Beier, K., Volkl, A., and Fahimi, H. D. TNF-α down-regulates the peroxisome proliferator activated receptor-α and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Lett., 412: 385-387, 1997.
21. Collins, A. T., Zhiming, B., Gilmore, K., and Neal, D. E. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J. Endocrinol., 143: 269-277, 1994.
22. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
23. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
24. Williams, J. G., and Mason, P. J. Hybridisation in the analysis of RNA. In: B. D. Hames and S. J. Higgins, (eds.), Nucleic Acid Hybridisation: A Practical Approach, pp. 139-160. Oxford, United Kingdom: IRL Press. 1987.
25. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
26. Brandt, J. M., Djouadi, F., and Kelly, D. P. Fatty acids activate transcription of muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α. J. Biol. Chem., 273: 23786-23792, 1998.
27. Sher, T., Yi, H-F., McBride, O. W., and Gonzalez, F. J. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry, 32: 5598-5604, 1993.
28. Moller Jensen, O., Esteve, J., Moller, H., and Renard, H. Cancer in the European community and its member states. Eur. J. Cancer, 26: 1167-1256, 1990.
29. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics 1996. CA Cancer J. Clin., 65: 5-27, 1996.
30. Wolf, D. A., Schulz, P., and Fittler, F. Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol. Endocrinol., 6: 753-762, 1992.
31. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. Molecular cloning of a complimentary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
32. Seregni, E., Botti, C., Ballabio, G., and Bombardieri, E. Biochemical characteristics and recent biological knowledge on prostate-specific antigen. Tumori, 80: 72-77, 1996.
33. Betts, A. M., Waite, I., Neal, D. E., and Robson, C. N. Androgen regulation of ornithine decarboxylase in human prostatic cells identified using differential display. FEBS Lett., 405: 328-332, 1997.
34. Betts, A. M., Collett, G. P., Neal, D. E., and Robson, C. N. Paracrine regulation of talin mRNA expression by androgen in human prostate. FEBS Lett., 434: 66-70, 1998.
35. Wolf, D. A., Herzinger, T., Hermeking, H., Blaschke, D., and Horz, W. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol. Endocrinol., 7: 924-936, 1993.
36. Ideta, R., Yeh, S. Y., Lee, Y. F., Adachi, K., Takeda, H., Su, C. Y., Saltzman, A., and Chang, C. S. Gene expression of the androgen repressed rat TR2 orphan receptor: a member of the steroid receptor superfamily. Endocrine, 3: 277-283, 1995.
37. Mizokami, A., and Chang, C. Induction of translation by the 5′-untranslated region of human androgen receptor mRNA. J. Biol. Chem., 269: 25655-25659, 1994.
38. Sundseth, S. S., and Waxman, D. J. Sex-dependent expression and clofibrate inducibility pf cytochrome-P450 4A fatty acid omega-hydroxylases: male specificity of liver and kidney CYP4A2 messenger-RNA and tissue-specific regulation by growth hormone and testosterone. J. Biol. Chem., 267: 3915-3921, 1992.
39. Paul, H. S., Sekas, G., and Winters, S. J. Role of testosterone in the induction of hepatic peroxisome proliferation by clofibrate. Metabolism, 43: 168-173, 1994.
40. Hayashi, F., Tamura, H., Yamada, J., Kasai, H., and Suga, T. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator in male F344 rats. Carcinogenesis (Lond.), 15: 2215-2219, 1994.
41. Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., and Evans, R. M. Role of CBP/ p300 in nuclear receptor signalling. Nature (Lond.), 383: 99-103, 1996.
42. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A-M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., and Auwerx, J. PPARα and PPAR-γ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J., 15: 5336-5348, 1996.
43. Schoonjans, K., Staels, B., and Auwerx, J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta, 1302: 93-109, 1996.
44. Swinnen, J. V., Vanveldhoven, P. P., Esquenet, M., Heyns, W., and Verhoeven, G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic cell-line LNCaP. Endocrinology, 137: 4468-4474, 1996.
45. Swinnen, J. V., Esquenet, M., Goossens, K., Heyns, W., and Verhoeven, G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res., 57: 1086-1090, 1997.
46. Swinnen, J. V., Ulrix, W., Heyns, W., and Verhoeven, G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA, 94: 12975-12980, 1997.
47. Schmidt, A., Endo, N., Rutledge, S. J., Vogel, R., Shinar, D., and Rodan, G. A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol., 6: 1634-1641, 1992.
48. Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., and Reddy, J. K. Cloning of a new member of the peroxisome proliferator activated receptor gene family from mouse liver. J. Biol. Chem., 268: 26817-26820, 1993.
49. Chinetti, G., Griglio, S., Antonucci, M., Pineda Torra, I., Delerive, P., Majd, Z., Fruchart, J-C., Chapman, J., Najib, J., and Staels, B. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem., 273; 25573-25580, 1998.
50. Bonkhoff, H., and Remberger, K. Differentiation pathway and histogenic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate, 28: 98-106, 1996.
51. Kilgore, M. W., Tate, P. L., Rai, S., Sengoku, E., and Price, T. M. MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response. Mol. Cell. Endocrinol., 129: 229-235, 1997.
52. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., and Spiegelman, B. M. Terminal differentiation of human breast cancer through PPAR γ. Mol. Cell, 1: 465-470, 1998.
53. DuBois, R. N., Gupta, R., Brockman, J., Reddy, B. S., Krakow, S. L., and Lazar, M. A. The nuclear eicosanoid receptor, PPAR γ, is aberrantly expressed in colonic cancers. Carcinogenesis (Lond.), 19: 49-53, 1998.
54. Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., and Koeffler, H. P. Ligand for peroxisome proliferator-activated receptor γ (Triglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res., 58: 3344-3352, 1998.
55. Wang, Y., Corr, J. G., Thaler, H. T., Tao, Y., Fair, W. R., and Heston, W. D. W. Decreased growth of established human prostate LNCaP tumours in nude-mice fed a low-fat diet. J. Natl. Cancer Inst., 87: 1456-1462, 1995.
56. Bairati, I., Meyer, F., Fradet, Y., and Moore, L. Dietary fat and advanced prostate cancer. J. Urol., 159: 1271-1275, 1998.
57. Grasl-Kraupp, B., Bursch, W., Ruttkay-Nedecky, B., Wagner, A., Lauer, B., and Schulte-Hermann, R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. USA, 91: 9995-9999, 1994.